Aethlon Medical
AEMD
20 hedge funds and large institutions have $1.09M invested in Aethlon Medical in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
5% more funds holding
Funds holding: 19 → 20 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
41% less capital invested
Capital invested by funds: $1.85M → $1.09M (-$760K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Natixis
Paris,
France
|
+$27.9K |
| 2 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$14K |
| 3 |
Truist Financial
Charlotte,
North Carolina
|
+$14K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$14K |
| 5 |
Citigroup
New York
|
+$9.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$395K |
| 2 |
Two Sigma Investments
New York
|
-$40K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$32.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$17K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$14K |
AEMD Hedge Fund Activity: Q2 2022 in Review
20 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q2 2022, worth a combined $1.09M — down 41% from $1.85M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AEMD positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Natixis, opening a new position worth an estimated $27.9K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $395K sold.
- 20 institutional investors held Aethlon Medical (AEMD) as of Q2 2022, up from 19 in Q1 2022.
- Funds reported $1.09M of Aethlon Medical stock for Q2 2022, down 41% quarter-over-quarter.
- 5 funds opened new Aethlon Medical positions in Q2 2022 and 3 closed out, a net change of +2 holders.
- The largest Aethlon Medical buyer in Q2 2022 was Natixis, an estimated $27.9K added.
- The largest Aethlon Medical seller in Q2 2022 was Renaissance Technologies, an estimated $395K sold.
Based on aggregated 13F filings for Q2 2022.